南华生物(000504) - 2022 Q3 - 季度财报

Key Financial Data Key Accounting Data and Financial Indicators The company achieved significant revenue growth and turned profitable in the first three quarters of 2022, with net profit attributable to parent company shareholders up 106.44%, despite a decline in total assets Key Accounting Data and Financial Indicators | Indicator | Year-to-Date as of Report Period End | YTD vs. Prior Period Change | | :--- | :--- | :--- | | Operating Revenue (CNY) | 156,404,576.30 | 52.40% | | Net Profit Attributable to Shareholders of the Listed Company (CNY) | 540,721.32 | 106.44% | | Net Profit Attributable to Shareholders of the Listed Company After Deducting Non-recurring Gains and Losses (CNY) | -6,212,530.03 | 46.46% | | Net Cash Flow from Operating Activities (CNY) | 130,252,235.42 | 364.07% | | Basic Earnings Per Share (CNY/share) | 0.0017 | 106.30% | | Indicator | As of End of Current Period | Vs. Prior Year-End Change | | Total Assets (CNY) | 596,009,995.11 | -9.59% | | Total Equity Attributable to Shareholders of the Listed Company (CNY) | 17,181,115.40 | 3.25% | Non-recurring Gains and Losses and Their Amounts Year-to-date, non-recurring gains and losses totaled 6.75 million CNY, primarily from government grants, which was key to achieving positive net profit Non-recurring Gains and Losses | Item | YTD Amount (CNY) | Description | | :--- | :--- | :--- | | Government grants recognized in current profit or loss | 3,565,005.85 | - | | Other non-operating income and expenses apart from the above | 4,619,397.82 | - | | Impact on minority interests (after tax) | -1,282,115.66 | - | | Total | 6,753,251.35 | -- | Changes and Reasons for Key Financial Indicators Significant financial changes include increased financial assets held for trading, decreased prepayments, increased short-term borrowings, and reduced other payables; revenue grew over 50%, with credit impairment losses reversing Key Financial Indicator Changes and Reasons | Statement Item | Change Percentage | Reason for Change | | :--- | :--- | :--- | | Balance Sheet | | | | Financial assets held for trading | 2014.90% | Primarily due to debt-to-equity conversion by a subsidiary and current period purchases of wealth management products | | Prepayments | -70.90% | Due to recovery of business prepayments from canceled procurement agreements in the current period | | Short-term borrowings | 91.33% | Increase in bank borrowings | | Other payables | -35.93% | Primarily due to repayment of 100 million CNY loan from Caixin Financial Holdings in the current period | | Income Statement | | | | Operating revenue | 52.40% | Continued growth in the company's cell business and new heating business revenue compared to the prior period | | Operating cost | 282.60% | Increase in operating revenue led to a corresponding increase in costs | | Other income | 394.03% | Increase in government grants received in the current period | | Credit impairment losses | 150.01% | Recovery of accounts receivable from energy-saving and medical device trading businesses in the current period, leading to a reversal of corresponding bad debts | Shareholder Information Common Shareholder Shareholding As of the report period end, the company had 13,960 common shareholders; the controlling shareholder holds 25.58%, with some top shareholders having pledged shares - As of the report period end, the total number of common shareholders was 13,960[13] Top Ten Shareholders' Shareholding | Shareholder Name | Shareholder Type | Shareholding Percentage | Number of Shares Held | Pledge Status | | :--- | :--- | :--- | :--- | :--- | | Hunan Caixin Industrial Fund Management Co., Ltd. | State-owned Legal Person | 25.58% | 79,701,655 | None | | Shanghai Heping Bulk Equity Investment Fund Management Co., Ltd. | Domestic Non-state-owned Legal Person | 11.43% | 35,600,000 | Pledged 35,600,000 | | Hefei Xijing Technology Co., Ltd. | Domestic Non-state-owned Legal Person | 4.66% | 14,522,162 | None | - The company's controlling shareholder, Caixin Industrial Fund, has no related party or concerted action relationship with other shareholders; relationships among other circulating shareholders are unknown[14] Other Significant Matters Other Significant Matters No other significant matters required disclosure during the reporting period - The company had no other significant matters requiring disclosure in this reporting period[16] Quarterly Financial Statements (Unaudited) Consolidated Balance Sheet As of September 30, 2022, total assets were 596.01 million CNY, down 9.59%; total liabilities were 477.53 million CNY, down 13.01% due to debt repayment; equity attributable to parent company shareholders was 17.18 million CNY, a slight increase Consolidated Balance Sheet Data | Item | September 30, 2022 (CNY) | January 1, 2022 (CNY) | | :--- | :--- | :--- | | Total Assets | 596,009,995.11 | 659,245,600.20 | | Total Liabilities | 477,530,805.14 | 548,926,321.40 | | Total Equity Attributable to Parent Company Shareholders | 17,181,115.40 | 16,640,394.08 | | Total Equity | 118,479,189.97 | 110,319,278.80 | Consolidated Income Statement In the first three quarters of 2022, operating revenue reached 156.40 million CNY, up 52.40%, with total operating costs at 152.42 million CNY, up 40.70%; net profit was 8.16 million CNY, a turnaround from a 5.36 million CNY net loss, with parent company net profit at 0.54 million CNY Consolidated Income Statement Data | Item | Current Period Amount (CNY) | Prior Period Amount (CNY) | | :--- | :--- | :--- | | I. Total Operating Revenue | 156,404,576.30 | 102,630,862.82 | | II. Total Operating Costs | 152,421,445.83 | 108,336,750.17 | | III. Operating Profit | 8,389,117.25 | -6,144,236.87 | | IV. Total Profit | 13,007,165.63 | -3,236,487.92 | | V. Net Profit | 8,159,911.17 | -5,357,485.10 | | 1. Net Profit Attributable to Parent Company Shareholders | 540,721.32 | -8,401,491.52 | | 2. Minority Interests | 7,619,189.85 | 3,044,006.42 | Consolidated Cash Flow Statement In the first three quarters of 2022, operating cash flow was a strong net inflow of 130.25 million CNY, up 364.07%; investing cash flow was a net outflow of 20.89 million CNY, while financing cash flow was a net outflow of 73.54 million CNY due to debt repayment; cash and cash equivalents at period end totaled 188.83 million CNY Consolidated Cash Flow Statement Data | Item | Current Period Amount (CNY) | Prior Period Amount (CNY) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 130,252,235.42 | 28,067,646.06 | | Net Cash Flow from Investing Activities | -20,892,052.90 | -20,418,020.02 | | Net Cash Flow from Financing Activities | -73,539,523.05 | 24,749,939.87 | | Net Increase in Cash and Cash Equivalents | 35,820,788.38 | 32,399,541.03 | | Cash and Cash Equivalents at Period End | 188,825,485.09 | 99,437,580.79 | Audit Status The company's 2022 third-quarter report is unaudited - The company's third-quarter report is unaudited[24]